软骨
祖细胞
阿格里坎
医学
病理
骨髓
细胞生物学
II型胶原
人口
干细胞
免疫学
生物
解剖
骨关节炎
关节软骨
替代医学
环境卫生
作者
Mei Massengale,Justin Massengale,Catherine R. Benson,Ninib Barywano,Toshihiko Oki,Matthew L. Steinhauser,Alissa Wang,Deepak Balani,Luke S. Oh,Mark A. Randolph,Thomas J. Gill,Henry M. Kronenberg,David T. Scadden
出处
期刊:JCI insight
[American Society for Clinical Investigation]
日期:2023-09-07
卷期号:8 (17)
被引量:8
标识
DOI:10.1172/jci.insight.167858
摘要
The identity and origin of the stem/progenitor cells for adult joint cartilage repair remain unknown, impeding therapeutic development. Simulating the common therapeutic modality for cartilage repair in humans, i.e., full-thickness microfracture joint surgery, we combined the mouse full-thickness injury model with lineage tracing and identified a distinct skeletal progenitor cell type enabling long-term (beyond 7 days after injury) articular cartilage repair in vivo. Deriving from a population with active Prg4 expression in adulthood while lacking aggrecan expression, these progenitors proliferate, differentiate to express aggrecan and type II collagen, and predominate in long-term articular cartilage wounds, where they represent the principal repair progenitors in situ under native repair conditions without cellular transplantation. They originate outside the adult bone marrow or superficial zone articular cartilage. These findings have implications for skeletal biology and regenerative medicine for joint injury repair.
科研通智能强力驱动
Strongly Powered by AbleSci AI